Seltorexant for major depressive disorder
Kyle Valentino
1, 2, 3, 4, 5, 6, 7, 8, 9
,
Kayla M. Teopiz
1, 4, 7
,
Sabrina Wong
1, 2, 3, 4, 5, 6, 7, 8, 9
,
Melanie C. Zhang
8, 10, 11
,
Gia Han Le
1, 3, 4, 6, 7, 8, 9, 12, 13
,
Hayun Choi
1, 4, 7, 8, 10, 11, 14, 15
,
Hana Ballum
1, 4, 7
,
Christine Dri
1, 4, 7
,
William Cheung
1, 4, 7
,
Roger S. McIntyre
8, 10, 11
1
Brain and Cognition Discovery Foundation, Toronto, ON, Canada
|
3
Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada
|
4
Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada
|
6
Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada
|
7
Brain and Cognition Discovery Foundation
8
University of Toronto
|
9
University Health Network
14
Department of Psychiatry, Veteran Health Service Medical Center, Seoul, Republic of Korea
|
15
Veteran Health Service Medical Center
Publication type: Journal Article
Publication date: 2025-01-02
scimago Q1
wos Q2
SJR: 1.034
CiteScore: 4.7
Impact factor: 2.7
ISSN: 14728214, 17447623
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
Journal of Psychiatric Research
1 publication, 100%
|
|
|
1
|
Publishers
|
1
|
|
|
Elsevier
1 publication, 100%
|
|
|
1
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1
Total citations:
1
Citations from 2024:
1
(100%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Valentino K. et al. Seltorexant for major depressive disorder // Expert Opinion on Emerging Drugs. 2025. Vol. 30. No. 1. pp. 41-51.
GOST all authors (up to 50)
Copy
Valentino K. et al. Seltorexant for major depressive disorder // Expert Opinion on Emerging Drugs. 2025. Vol. 30. No. 1. pp. 41-51.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1080/14728214.2025.2452514
UR - https://www.tandfonline.com/doi/full/10.1080/14728214.2025.2452514
TI - Seltorexant for major depressive disorder
T2 - Expert Opinion on Emerging Drugs
AU - Valentino, Kyle
AU - Teopiz, Kayla M.
AU - Wong, Sabrina
AU - Zhang, Melanie C.
AU - Le, Gia Han
AU - Choi, Hayun
AU - Ballum, Hana
AU - Dri, Christine
AU - Cheung, William
AU - McIntyre, Roger S.
PY - 2025
DA - 2025/01/02
PB - Taylor & Francis
SP - 41-51
IS - 1
VL - 30
SN - 1472-8214
SN - 1744-7623
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2025_Valentino,
author = {Kyle Valentino and Kayla M. Teopiz and Sabrina Wong and Melanie C. Zhang and Gia Han Le and Hayun Choi and Hana Ballum and Christine Dri and William Cheung and Roger S. McIntyre and others},
title = {Seltorexant for major depressive disorder},
journal = {Expert Opinion on Emerging Drugs},
year = {2025},
volume = {30},
publisher = {Taylor & Francis},
month = {jan},
url = {https://www.tandfonline.com/doi/full/10.1080/14728214.2025.2452514},
number = {1},
pages = {41--51},
doi = {10.1080/14728214.2025.2452514}
}
Cite this
MLA
Copy
Valentino, Kyle, et al. “Seltorexant for major depressive disorder.” Expert Opinion on Emerging Drugs, vol. 30, no. 1, Jan. 2025, pp. 41-51. https://www.tandfonline.com/doi/full/10.1080/14728214.2025.2452514.